Vera Therapeutics, Inc. VERA

Set alert

31.97 USD +1.26 (+4.10%)

At closeNov 4, 2026, 5:03 PM EST

31.97 0.00 0.00%

After hours · Nov 4, 5:03 PM ET

30.73 Day range 32.18

23.05 52-week range 56.05

Held by insiders 1.01%

Held by institutions 119.14%

Float held by institutions 120.36%

Institutions 314

Top institutional holders
Holder	% held	Shares	Value	Reported
Blackrock Inc.	7.98%	5,747,760	183.76M	Jun 29, 2026
Avoro Capital Advisors LLC	7.94%	5,723,888	182.99M	Jun 29, 2026
State Street Corporation	5.76%	4,148,786	132.64M	Jun 29, 2026
Price (T.Rowe) Associates Inc	5.57%	4,012,936	128.29M	Jun 29, 2026
Deep Track Capital, Lp	5.55%	4,000,000	127.88M	Jun 29, 2026
Deerfield Management Company, L.P	5.43%	3,916,400	125.21M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	2.68%	1,933,728	61.82M	Jun 29, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	2.55%	1,834,397	58.65M	Sep 29, 2026
iShares Trust-iShares Russell 2000 ETF	2.30%	1,654,806	52.90M	Sep 29, 2026
T. Rowe Price New Horizons Fund, Inc.	1.41%	1,014,457	32.43M	Jun 29, 2026
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund	1.21%	871,547	27.86M	Aug 30, 2026
T. Rowe Price Health Sciences Fund, Inc.	1.09%	784,306	25.07M	Jun 29, 2026

VERA insiders
Insider	Relation	Latest transaction	Date	Shares held
BOMAN NANCY LEE M.D., PH.D.	Officer	Stock Award(Grant)	Aug 2, 2026	44,987
BRENNER ROBERT	Officer	Sale	Feb 22, 2026	50,947
CARTER JASON S	Officer	Sale	Nov 20, 2025	49,136
ENRIGHT PATRICK G.	Director	Purchase	Dec 10, 2025	5,400,090
FORDYCE MARSHALL	Chief Executive Officer	Sale	Sep 14, 2026	235,244
GRANT SEAN	Chief Financial Officer	Sale	Feb 22, 2026	119,181

Held by funds